GDUFA III Talks Completed; Fees will Fund Inspection, Complex Generic Improvements

Agreement reached
GDUFA III was the last of three FDA human drug and biologic user fee renewal agreements to be completed. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from User Fees

More from Pathways & Standards